• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
New mutation points in 23S rRNA gene associated with Helicobacter pylori resistance to clarithromycin in northeast China.中国东北地区23S rRNA基因中与幽门螺杆菌对克拉霉素耐药相关的新突变位点
World J Gastroenterol. 2004 Apr 1;10(7):1075-7. doi: 10.3748/wjg.v10.i7.1075.
2
Influence of a 23S ribosomal RNA mutation in Helicobacter pylori strains on the in vitro synergistic effect of clarithromycin and amoxicillin.幽门螺杆菌菌株中23S核糖体RNA突变对克拉霉素和阿莫西林体外协同效应的影响。
BMC Res Notes. 2012 Oct 30;5:603. doi: 10.1186/1756-0500-5-603.
3
Characterisation of point mutations in domain V of the 23S rRNA gene of clinical Helicobacter pylori strains and clarithromycin-resistant phenotype in central Vietnam.中越地区临床幽门螺杆菌分离株 23S rRNA 基因 V 区点突变特征及其克拉霉素耐药表型分析。
J Glob Antimicrob Resist. 2019 Mar;16:87-91. doi: 10.1016/j.jgar.2018.09.012. Epub 2018 Sep 25.
4
[Prevalence and mechanism of Helicobacter pylori resistance to clarithromycin in children].[儿童幽门螺杆菌对克拉霉素耐药的患病率及机制]
Zhonghua Er Ke Za Zhi. 2004 Nov;42(11):850-3.
5
Novel genotypes in Helicobacter pylori involving domain V of the 23S rRNA gene.幽门螺杆菌中涉及23S rRNA基因第五结构域的新型基因型。
Helicobacter. 2007 Oct;12(5):505-9. doi: 10.1111/j.1523-5378.2007.00506.x.
6
Antibiotic susceptibility of Helicobacter pylori strains isolated from Iranian children: High frequency of A2143G point mutation associated with clarithromycin resistance.从伊朗儿童中分离的幽门螺杆菌菌株的抗生素敏感性:与克拉霉素耐药相关的 A2143G 点突变的高频率。
J Glob Antimicrob Resist. 2017 Sep;10:131-135. doi: 10.1016/j.jgar.2017.04.011. Epub 2017 Jul 15.
7
High Prevalence of Helicobacter pylori Resistance to Clarithromycin: a Hospital-Based Cross-Sectional Study in Nakhon Ratchasima Province, Northeast of Thailand.幽门螺杆菌对克拉霉素耐药的高流行率:泰国东北部呵叻府一项基于医院的横断面研究
Asian Pac J Cancer Prev. 2015;16(18):8281-5. doi: 10.7314/apjcp.2015.16.18.8281.
8
Primary resistance of Helicobacter pylori to antimicrobial agents in Polish children.波兰儿童幽门螺杆菌对抗菌药物的原发性耐药性。
Acta Microbiol Pol. 2002;51(3):255-63.
9
[Antibiotic resistance of Helicobacter pylori in children and macrolide-resistant genotypes in Helicobacter pylori].[儿童幽门螺杆菌的抗生素耐药性及幽门螺杆菌大环内酯类耐药基因型]
Zhonghua Yi Xue Za Zhi. 2014 Mar 4;94(8):563-6.
10
Characterization of 23S rRNA gene mutation in primary and secondary clarithromycin-resistant Helicobacter pylori strains from East China.华东地区原发性和继发性克拉霉素耐药幽门螺杆菌菌株中23S rRNA基因突变的特征分析
Turk J Gastroenterol. 2013;24(1):5-9. doi: 10.4318/tjg.2013.0525.

引用本文的文献

1
Antibiotic Resistance, Susceptibility Testing and Stewardship in Infection.感染中的抗生素耐药性、药敏试验和管理
Int J Mol Sci. 2023 Jul 20;24(14):11708. doi: 10.3390/ijms241411708.
2
Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Infection: A Systematic Review and Meta-Analysis.易感性指导治疗与含铋四联疗法作为感染一线治疗的比较:一项系统评价和荟萃分析
Front Med (Lausanne). 2022 Mar 24;9:844915. doi: 10.3389/fmed.2022.844915. eCollection 2022.
3
Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications.幽门螺杆菌感染和抗生素耐药性 - 从生物学到临床意义。
Nat Rev Gastroenterol Hepatol. 2021 Sep;18(9):613-629. doi: 10.1038/s41575-021-00449-x. Epub 2021 May 17.
4
Trends in resistance to clarithromycin: from phenotypic to genomic approaches.克拉霉素耐药趋势:从表型到基因组方法。
Microb Genom. 2020 Mar;6(3). doi: 10.1099/mgen.0.000344.
5
Mutations Conferring Resistance to Fluoroquinolones and Clarithromycin among Dyspeptic Patients Attending a Tertiary Hospital, Tanzania.坦桑尼亚一家三级医院消化不良患者中对氟喹诺酮类药物和克拉霉素耐药的突变体。
Can J Gastroenterol Hepatol. 2019 Jul 1;2019:8481375. doi: 10.1155/2019/8481375. eCollection 2019.
6
High primary resistance to metronidazole and levofloxacin, and a moderate resistance to clarithromycin in isolated from Karnataka patients.从卡纳塔克邦患者中分离出的菌株对甲硝唑和左氧氟沙星具有较高的原发性耐药性,对克拉霉素具有中度耐药性。
Gut Pathog. 2019 May 13;11:21. doi: 10.1186/s13099-019-0305-x. eCollection 2019.
7
Genetic Determinants and Prediction of Antibiotic Resistance Phenotypes in .遗传决定因素与……中抗生素耐药表型的预测
J Clin Med. 2019 Jan 7;8(1):53. doi: 10.3390/jcm8010053.
8
The magnitude of antibiotic resistance to Helicobacter pylori in Africa and identified mutations which confer resistance to antibiotics: systematic review and meta-analysis.非洲幽门螺杆菌对抗生素耐药性的程度以及鉴定出的赋予抗生素耐药性的突变:系统评价和荟萃分析。
BMC Infect Dis. 2018 Apr 24;18(1):193. doi: 10.1186/s12879-018-3099-4.
9
Punctual mutations in gene of clarithromycin-resistant in Colombian populations.哥伦比亚人群克拉霉素耐药基因中的准时突变。
World J Gastroenterol. 2018 Apr 14;24(14):1531-1539. doi: 10.3748/wjg.v24.i14.1531.
10
Novel and Effective Therapeutic Regimens for in an Era of Increasing Antibiotic Resistance.抗生素耐药性不断增加的时代下针对[具体病症,原文缺失]的新型有效治疗方案
Front Cell Infect Microbiol. 2017 May 5;7:168. doi: 10.3389/fcimb.2017.00168. eCollection 2017.

本文引用的文献

1
Prevalence of Helicobacter pylori infection among low socio-economic workers.社会经济地位较低的劳动者中幽门螺杆菌感染的患病率
J Commun Dis. 2002 Sep;34(3):179-84.
2
[Meta-analysis on the epidemiology of Helicobacter pylori infection in China].[中国幽门螺杆菌感染流行病学的Meta分析]
Zhonghua Liu Xing Bing Xue Za Zhi. 2003 Jun;24(6):443-6.
3
[Epidemiology of Helicobacter pylori infection].
Lijec Vjesn. 2002 Sep;124 Suppl 1:5-9.
4
Helicobacter pylori infection and respiratory diseases: a review.幽门螺杆菌感染与呼吸道疾病:综述
World J Gastroenterol. 2003 Jan;9(1):5-8. doi: 10.3748/wjg.v9.i1.5.
5
Helicobacter pylori infection and gastric cancer: evidence from a retrospective cohort study and nested case-control study in China.幽门螺杆菌感染与胃癌:来自中国一项回顾性队列研究和巢式病例对照研究的证据
World J Gastroenterol. 2002 Dec;8(6):1103-7. doi: 10.3748/wjg.v8.i6.1103.
6
New site of modification of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolates.与幽门螺杆菌临床分离株克拉霉素耐药性相关的23S rRNA新修饰位点。
Antimicrob Agents Chemother. 2002 Dec;46(12):3765-9. doi: 10.1128/AAC.46.12.3765-3769.2002.
7
Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999.美国幽门螺杆菌耐药的危险因素:1993 - 1999年幽门螺杆菌抗菌药物耐药监测合作研究(SHARP研究)
Ann Intern Med. 2002 Jan 1;136(1):13-24. doi: 10.7326/0003-4819-136-1-200201010-00008.
8
Diagnosis of Helicobacter pylori infection by stool antigen test in southern Taiwan.台湾南部地区采用粪便抗原检测诊断幽门螺杆菌感染
Kaohsiung J Med Sci. 2001 Jun;17(7):344-50.
9
Comparison of the Etest and the NCCLS-approved agar dilution method to detect metronidazole and clarithromycin resistant Helicobacter pylori.比较Etest法与美国国家临床实验室标准委员会(NCCLS)认可的琼脂稀释法检测耐甲硝唑和克拉霉素幽门螺杆菌的效果。
Int J Antimicrob Agents. 2001 Jan;17(1):39-44. doi: 10.1016/s0924-8579(00)00320-4.
10
The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori.抗生素耐药性对三种7天根除幽门螺杆菌方案疗效的影响。
Aliment Pharmacol Ther. 2000 Jul;14(7):893-900. doi: 10.1046/j.1365-2036.2000.00780.x.

中国东北地区23S rRNA基因中与幽门螺杆菌对克拉霉素耐药相关的新突变位点

New mutation points in 23S rRNA gene associated with Helicobacter pylori resistance to clarithromycin in northeast China.

作者信息

Hao Qing, Li Yan, Zhang Zhi-Jie, Liu Yong, Gao Hong

机构信息

Department of Gastroenterology, the 2nd Affiliated Hospital, China Medical University, Shenyang 110004, Liaoning Province, China.

出版信息

World J Gastroenterol. 2004 Apr 1;10(7):1075-7. doi: 10.3748/wjg.v10.i7.1075.

DOI:10.3748/wjg.v10.i7.1075
PMID:15052698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4717104/
Abstract

AIM

To investigate the resistance rate of Helicobacter pylori (H pylori ) to clarithromycin, metronidazole, amoxicillin and tetracycline to guide clinical practice, and to study the mechanism of H pylori resistant to clarithromycin.

METHODS

Thirty H pylori strains were isolated from the mucosa of peptic ulcer, gastric tumor and chronic gastritis patients, then the minimal inhibitory concentration (MIC) to clarithromycin, metronidazole, amoxicillin and tetracycline was evaluated by E-test method. The sequence analysis of PCR fragments was conducted in 23S rRNA gene of H pylori resistant to clarithromycin to get the resistance mechanism of the bacteria.

RESULTS

Among 30 H pylori strains, 7 cases were resistant to clarithromycin, 12 to metronidazole, 2 to tetracycline and no strain was found to be resistant to amoxicillin. The resistance rates were 23.3%, 40%, 6.7% and 0%, respectively. Three new mutation points were found to be related to the clarithromycin resistance in H pylori isolates, which were G2224A, C2245T and T2289C.

CONCLUSION

In northeast China, H pylori shows high resistance to metronidazole, while sensitive to amoxicillin. The mechanism of resistance to clarithromycin may be related to the mutation of G2224A, C2245T and T2289C in the 23S rRNA gene.

摘要

目的

研究幽门螺杆菌(H pylori)对克拉霉素、甲硝唑、阿莫西林和四环素的耐药率以指导临床实践,并探讨H pylori对克拉霉素耐药的机制。

方法

从消化性溃疡、胃肿瘤及慢性胃炎患者的黏膜中分离出30株H pylori菌株,然后采用E-test法评估其对克拉霉素、甲硝唑、阿莫西林和四环素的最低抑菌浓度(MIC)。对克拉霉素耐药的H pylori的23S rRNA基因进行PCR片段序列分析,以了解细菌的耐药机制。

结果

30株H pylori菌株中,7株对克拉霉素耐药,12株对甲硝唑耐药,2株对四环素耐药,未发现对阿莫西林耐药的菌株。耐药率分别为23.3%、40%、6.7%和0%。发现3个新的突变位点与H pylori分离株对克拉霉素的耐药性有关,分别为G2224A、C2245T和T2289C。

结论

在中国东北地区,H pylori对甲硝唑耐药率高,而对阿莫西林敏感。对克拉霉素耐药的机制可能与23S rRNA基因中的G2224A、C2245T和T2289C突变有关。